Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7E9Q | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) | |
| 7E9Q | 7E9Q | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 out RBD, state3) | |
| 7E9P | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the RBD and 35B5 Fab) | |
| 7E9P | 7E9P | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(state2, local refinement of the RBD and 35B5 Fab) | |
| 7E9O | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) | |
| 7E9O | 7E9O | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(3 up RBDs, state2) | |
| 7E9N | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1) | |
| 7E9N | 7E9N | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with 35B5 Fab(1 down RBD, state1) | |
| 7E9L | Q5NDF2 | Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man short peptide) | |
| 7E9L | 7E9L | Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man short peptide) | |
| 7E9K | Q5NDF2 | Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man long peptide) | |
| 7E9K | 7E9K | Crystal Structure of POMGNT2 in complex with UDP and mono-mannosyl peptide (379Man long peptide) | |
| 7E9J | Q5NDF2 | Crystal Structure of POMGNT2 in complex with UDP | Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (E.C.2.4.1.312) |
| 7E8M | P0DTC2 | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
| 7E8M | 7E8M | Crystal structure of SARS-CoV-2 antibody P2C-1F11 with mutated RBD | |
| 7E7Q | P78363 | Cryo-EM structure of human ABCA4 in ATP-bound state | Retinal-specific phospholipid-transporting ATPase ABCA4 (E.C.7.6.2.1) |
| 7E7O | P78363 | Cryo-EM structure of human ABCA4 in NRPE-bound state | Retinal-specific phospholipid-transporting ATPase ABCA4 (E.C.7.6.2.1) |
| 7E7M | A0A6H3FYP2 | Crystal Structure Analysis of the Streptococcus agalactiae Ribose Binding Protein RbsB | |
| 7E7I | P78363 | Cryo-EM structure of human ABCA4 in the apo state | Retinal-specific phospholipid-transporting ATPase ABCA4 (E.C.7.6.2.1) |
| 7E7D | P02452 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
| 7E7D | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
| 7E7B | P02452 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
| 7E7B | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate | |
| 7E78 | Q1PBI3 | the structure of cytosolic TaPGI with substrate | |
| 7E71 | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 ms structure | |
| 7E71 | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 ms structure | |
| 7E70 | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 250 microsecond structure | |
| 7E70 | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 250 microsecond structure | |
| 7E6Z | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure | |
| 7E6Z | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 50 microsecond structure | |
| 7E6Y | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure | |
| 7E6Y | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 1 microsecond structure | |
| 7E6X | Q8RUT8 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure | |
| 7E6X | Q93WP2 | Time-resolved serial femtosecond crystallography reveals early structural changes in channelrhodopsin: 4 ms structure | |
| 7E6T | P41180 | Structural insights into the activation of human calcium-sensing receptor | |
| 7E6Q | A1ILL9 | Crystal structure of influenza A virus neuraminidase N5 complexed with 4'-phenyl-1,2,3-triazolylated oseltamivir carboxylate | |
| 7E6I | P48828 | Glucose-6-phosphate dehydrogenase in complex with its substrate glucose-6-phosphate | |
| 7E5S | P0DTC2 | SARS-CoV-2 S trimer with four-antibody cocktail complex | |
| 7E5S | 7E5S | SARS-CoV-2 S trimer with four-antibody cocktail complex | |
| 7E5R | P0DTC2 | SARS-CoV-2 S trimer with three-antibody cocktail complex | |
| 7E5R | 7E5R | SARS-CoV-2 S trimer with three-antibody cocktail complex | |
| 7E5O | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7E5O | 7E5O | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7E5M | P09758 | crystal structure of trans assembled human TROP-2 | |
| 7E57 | Q7TS55 | Crystal structure of murine GITR-GITRL complex | |
| 7E57 | O35714 | Crystal structure of murine GITR-GITRL complex | |
| 7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3L | 7E3L | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3K | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
| 7E3K | 7E3K | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants |
